Sygnature Discovery, a UK provider of integrated drug discovery resource and expertise has invested, through its parent Sygil Group, in a new start-up company, Peak Proteins. The investment in Peak Proteins is part of an on-going strategy to build and expand the group’s capabilities. The deal, which was signed in December 2015, sees Sygil making a significant financial investment in the BioHub-based business at Alderley Park, Cheshire, UK. This partnership with Peak Proteins adds protein product...